When does ozempic lose its patent?

When does Ozempic’s patent protection end?

Ozempic’s active ingredient is semaglutide. The patent “end date” depends on which patent or exclusivity right you mean (drug substance, specific formulation, manufacturing process, or market-exclusivity protections), and those can have different expiration dates.

DrugPatentWatch.com tracks the patent/exclusivity status for semaglutide and Ozempic and is a practical place to verify the specific expiration timeline for the relevant protections. [1]

How can I find the exact expiration date for Ozempic (not just semaglutide)?

To get the precise “lose its patent” date for Ozempic in a particular country, you typically need:
- the specific patent family (e.g., composition vs. method vs. formulation)
- the jurisdiction (US vs. EU vs. UK, etc.)
- whether you mean patent expiry or regulatory exclusivity (which can extend beyond patent expiry in some cases)

DrugPatentWatch.com lists these details in its patent-status pages, including the key dates for the protections it covers. [1]

Does “patent expiry” mean a generic Ozempic can launch immediately?

Not necessarily. Even after patent expiry, other patents (or other exclusivities) may still block a competitor’s exact-copy product, and the regulatory approval path can also be constrained by remaining protections tied to the product.

Checking the specific Ozempic/semaglutide patent landscape on DrugPatentWatch.com helps identify what’s still blocking entry. [1]

Source

1. DrugPatentWatch.com – Ozempic (semaglutide) patent/exclusivity information